- Home
- TNGX vs REFI Comparison
TNGX vs REFI Comparison
Compare TNGX & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- REFI
- Stock Information
- Founded
- TNGX 2014
- REFI 2021
- Country
- TNGX United States
- REFI United States
- Employees
- TNGX N/A
- REFI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- REFI Real Estate Investment Trusts
- Sector
- TNGX Health Care
- REFI Real Estate
- Exchange
- TNGX Nasdaq
- REFI Nasdaq
- Market Cap
- TNGX 317.4M
- REFI 314.2M
- IPO Year
- TNGX N/A
- REFI 2021
- Fundamental
- Price
- TNGX $1.76
- REFI $15.39
- Analyst Decision
- TNGX Strong Buy
- REFI Strong Buy
- Analyst Count
- TNGX 7
- REFI 3
- Target Price
- TNGX $12.33
- REFI $20.00
- AVG Volume (30 Days)
- TNGX 801.9K
- REFI 193.1K
- Earning Date
- TNGX 05-07-2025
- REFI 03-12-2025
- Dividend Yield
- TNGX N/A
- REFI 13.32%
- EPS Growth
- TNGX N/A
- REFI N/A
- EPS
- TNGX N/A
- REFI 1.88
- Revenue
- TNGX $42,069,000.00
- REFI $55,534,183.00
- Revenue This Year
- TNGX N/A
- REFI N/A
- Revenue Next Year
- TNGX N/A
- REFI N/A
- P/E Ratio
- TNGX N/A
- REFI $8.23
- Revenue Growth
- TNGX 15.17
- REFI N/A
- 52 Week Low
- TNGX $1.71
- REFI $14.82
- 52 Week High
- TNGX $12.02
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- TNGX 33.97
- REFI 39.44
- Support Level
- TNGX $1.80
- REFI $15.28
- Resistance Level
- TNGX $2.04
- REFI $15.67
- Average True Range (ATR)
- TNGX 0.18
- REFI 0.30
- MACD
- TNGX 0.01
- REFI -0.07
- Stochastic Oscillator
- TNGX 20.19
- REFI 26.05
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.